BONY LESION ANALYSIS IN CARCINOMA PROSTATE: M.D.P. BONE SCAN VS. GALLIUM-68 PSMA-11 PET/CT
Journal of Ayub Medical College Abbottabad · 2023
DOI: 10.55519/jamc-03-12049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ayub Medical College Abbottabad, 2023. Verfasst von Haider Ali und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of nuclear medicine and molecular imaging, Sindh Institute of Urology & Transplantation, Karachi, Pakistan. Hauptthemen laut MEDLINE: Bone Neoplasms, Carcinoma, Diphosphonates, Gallium Isotopes. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).
Abstract (Originalsprache)
Background
Prostate cancer is the cause of the highest cancer-related death in males, 5-year survival is 31% in metastatic disease, and bone is a common site of metastases. Bone scintigraphy is a routinely used imaging modality for detecting skeletal metastases. It has variable sensitivity of 52-100%, whereas PSMA PET/CT scans have better sensitivity approaching 100%, so we determined the diagnostic accuracy, sensitivity, and specificity of planar M.D.P. (methylene diphosphonate) bone scintigraphy.
Methods
This analytical cross-sectional study was conducted at the N.M. & molecular imaging department of S.I.U.T. Karachi. Bone scans and PSMA-PET/CT scans of all patients who were visited from Janury-2018 to January 2023 were reviewed and interpreted by a nuclear physician& radiologist team. Inclusion criteria were histopathology-proven prostate cancer patients who had a bone scan and PSMA PET/CT scan within one month and had not received any treatment between scans.
Results
Among 70 scans, 38 (54.2%) were positive for bone lesions. A total of 18 (47%) patients had positive bony lesions on both PSMA-PET/CT and Bone scintigraphy. Among 38 bone lesions positive patients, in eleven patients, bone lesions were detected only on PET/CT scans, whereas nine were positive only on Bone scans. The mean S.U.V. max of all bony lesions was 19.15 (range 3.2-57.5). The bone scan's sensitivity, specificity, and accuracy were 62.07%, 78.05%, and 62.87%, respectively.
Conclusion
PSMA-PET/CT is better than bone Scintigraphy for detecting skeletal metastases. However, outcomes of bone scintigraphy may be improved when Tc-PSMA receptor bone scintigraphy is used.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of nuclear medicine and molecular imaging, Sindh Institute of Urology & Transplantation, Karachi, Pakistan.
Zitieren
APA
Ali, H., Rashid Ul Amin, S., Hai, A., & Nizar, N. (2023). BONY LESION ANALYSIS IN CARCINOMA PROSTATE: M.D.P. BONE SCAN VS. GALLIUM-68 PSMA-11 PET/CT. Journal of Ayub Medical College Abbottabad. https://doi.org/10.55519/jamc-03-12049
Vancouver
Ali H, Rashid Ul Amin S, Hai A, Nizar N. BONY LESION ANALYSIS IN CARCINOMA PROSTATE: M.D.P. BONE SCAN VS. GALLIUM-68 PSMA-11 PET/CT. Journal of Ayub Medical College Abbottabad. 2023. doi:10.55519/jamc-03-12049
BibTeX
@article{Ali2023,
author = {Ali, Haider and Rashid Ul Amin, Syed and Hai, Abdul and Nizar, Noureen},
title = {BONY LESION ANALYSIS IN CARCINOMA PROSTATE: M.D.P. BONE SCAN VS. GALLIUM-68 PSMA-11 PET/CT},
journal = {Journal of Ayub Medical College Abbottabad},
year = {2023},
doi = {10.55519/jamc-03-12049}
}
EUVIMED